Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
2004 1
2005 1
2007 1
2008 4
2009 2
2010 3
2011 7
2012 5
2013 3
2014 2
2015 4
2016 5
2017 2
2018 3
2019 6
2020 5
2021 4
2022 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice.
Suárez-García I, Alejos B, Hernando V, Viñuela L, Vera García M, Rial-Crestelo D, Pérez Elías MJ, Albendín Iglesias H, Peraire J, Tiraboschi J, Díaz A, Moreno S, Jarrín I; Cohort of the Spanish HIV/AIDS Research Network (CoRIS). Suárez-García I, et al. J Antimicrob Chemother. 2023 Jun 1;78(6):1423-1432. doi: 10.1093/jac/dkad102. J Antimicrob Chemother. 2023. PMID: 37099559 Free PMC article.
Patient-Reported Outcomes (PROs) in HIV Infection: Points to Consider and Challenges.
Antela A, Bernardino JI, de Quirós JCL, Bachiller P, Fuster-RuizdeApodaca MJ, Puig J, Rodríguez S, Castrejón I, Álvarez B, Hermenegildo M. Antela A, et al. Among authors: de quiros jcl. Infect Dis Ther. 2022 Oct;11(5):2017-2033. doi: 10.1007/s40121-022-00678-w. Epub 2022 Sep 6. Infect Dis Ther. 2022. PMID: 36066841 Free PMC article.
Use of Generic Antiretroviral Drugs and Single-Tablet Regimen De-Simplification for the Treatment of HIV Infection in Spain.
Ruiz-Algueró M, Alejos B, García Yubero C, Riera Jaume M, Antonio Iribarren J, Asensi V, Pasquau F, Galera CE, Pascual-Carrasco M, Muñoz A, Jarrín I, Suárez-García I; CoRIS Cohort. Ruiz-Algueró M, et al. AIDS Res Hum Retroviruses. 2022 Jun;38(6):433-440. doi: 10.1089/AID.2021.0122. Epub 2022 May 2. AIDS Res Hum Retroviruses. 2022. PMID: 35357907
SARS-COV-2 Infection in People Living with HIV: Experience from a Tertiary Hospital in Madrid.
González Guembe M, Tisner Pensado Y, Tejerina Picado F, Diez C, Pérez Latorre L, Fanciulli C, Parras Vázquez F, López Bernaldo de Quirós JC, Berenguer J, Padilla Ortega B, Machado M, Valerio Minero M, Muñoz Garcia P, Bouza Santiago E, Galar A, Catalan P, Alonso R, Bellón JM, Aldámiz-Echevarría Lois T; Gregorio Marañón Microbiology-ID COVID 19 Study Group. González Guembe M, et al. Among authors: lopez bernaldo de quiros jc. AIDS Res Hum Retroviruses. 2022 May;38(5):394-398. doi: 10.1089/AID.2021.0159. Epub 2022 Jan 28. AIDS Res Hum Retroviruses. 2022. PMID: 34969259
Redefining therapeutic success in HIV patients: an expert view.
Antela A, Rivero A, Llibre JM, Moreno S; RET Group. Antela A, et al. J Antimicrob Chemother. 2021 Sep 15;76(10):2501-2518. doi: 10.1093/jac/dkab168. J Antimicrob Chemother. 2021. PMID: 34077524 Free PMC article. Review.
Self-rated health among people living with HIV in Spain in 2019: a cross-sectional study.
Ruiz-Algueró M, Hernando V, Marcos H, Gutiérrez G, Pérez-Elías MJ, López-Bernaldo de Quirós JC, Pulido F, Górgolas M, Sanz J, Suarez-García I, Fernandez MT, Losa JE, Pérez JL, Ladrero MO, Prieto MÁ, González G, Izquierdo A, Viloria LJ, López I, Martínez E, Castrillejo D, Aranguren R, Belmonte MA, Aranda-García IV, Arraiza A, Diaz A; Hospital Survey Study Group. Ruiz-Algueró M, et al. Among authors: lopez bernaldo de quiros jc. BMC Infect Dis. 2021 Jan 30;21(1):129. doi: 10.1186/s12879-021-05815-3. BMC Infect Dis. 2021. PMID: 33516173 Free PMC article.
Clinical course of severe patients with COVID-19 treated with tocilizumab: report from a cohort study in Spain.
Chamorro-de-Vega E, Rodriguez-Gonzalez CG, Manrique-Rodríguez S, Lobato-Matilla E, García-Moreno F, Olmedo M, Correa-Rocha R, Valerio M, Aldámiz-Echevarria T, Machado M, Sancho-Gonzalez M, Lopez-Bernaldo-de-Quirós JC, Ruiz-Briones P, Romero-Jiménez R, Sarobe-González C, Gimenez-Manzorro A, Collado-Borrell R, Fernandez-Llamazares CM, Revuelta-Herrero JL, Somoza-Fernandez B, Garcia-Sanchez S, Taladriz-Sender I, Bouza E, Herranz A, Muñoz P, Sanjurjo M. Chamorro-de-Vega E, et al. Among authors: lopez bernaldo de quiros jc. Expert Rev Clin Pharmacol. 2021 Feb;14(2):249-260. doi: 10.1080/17512433.2021.1875819. Epub 2021 Jan 26. Expert Rev Clin Pharmacol. 2021. PMID: 33499687 Free PMC article.
Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: a multicentre cohort study.
Suárez-García I, Moreno C, Ruiz-Algueró M, Pérez-Elías MJ, Navarro M, Díez Martínez M, Viciana P, Pérez-Martínez L, Górgolas M, Amador C, de Zárraga MA, Jarrín I; Cohort of the Spanish HIV/AIDS Research Network (CoRIS). Suárez-García I, et al. AIDS Res Ther. 2020 Jul 20;17(1):45. doi: 10.1186/s12981-020-00302-2. AIDS Res Ther. 2020. PMID: 32690099 Free PMC article.
56 results